University of Kansas Medical Center News

KU Medical Center was a site in a study published in JAMA that identified a dozen symptoms and a scoring system to identify long COVID in adults.

Commentary seeks to set an agenda for national problem of cancer disparities in those who have been incarcerated.

KU School of Medicine ranked 5th among all public medical schools in the country in the percentage of physicians practicing in rural areas and 9th among public institutions in producing primary care physicians.

The “Eat, Sleep, Console” care approach was more effective than standard of care to treat newborns exposed to opioids in the womb, according to a national clinical trial in which KU Medical Center participated.

The Center for Clinical Research, the investigative center of the University of Kansas School of Medicine-Wichita, is reaching out to rural residents via telehealth, telephone and mail service.

Researchers are conducting a clinical trial for a new drug that seeks to address the underlying cause of APOL1-mediated kidney disease rather than managing its symptoms.

Robert Deady has no scientific degree, but his dedication to the work of KU ADRC earns him the title (and award) of Citizen Scientist.

The new cryogenic electron microscope can reveal the structure of flash-frozen proteins and other biomolecules at nearly atomic resolution, enabling researchers to understand diseases and design drugs to fight them.

KU Medical Center researcher published in NEJM study showing large-core strokes can be treated with vacuum to retrieve clot

United in their fight against cancer, divided over who should be Super Bowl champions, prestigious cancer centers in Kansas City and Philadelphia enjoy friendly rivalry.

KU researcher Sandra Billinger, Ph.D., was part of a multi-site study that may change how stroke rehabilitation is conducted.

The annual K-INBRE Symposium gives promising students in Kansas and Oklahoma a chance to pursue research topics in the biosciences.

Available in English and Spanish, CareTEXT was developed by the KU Alzheimer’s Disease Research Center to help caregivers of people with dementia take care of their loved one as well as themselves.

New mural is part of the KU Cancer Center’s campaign to encourage diverse participation in cancer clinical trials.

Clinical trials can benefit you, no matter what stage of cancer you have. Here, Tara Lin, M.D., professor of hematologic malignancies and cellular therapeutics at KU Medical Center and medical director of the Clinical Trials Office at The University of Kansas Cancer Center, explains five reasons to consider participating in the testing of a novel cancer treatment.

Sharla Smith, Ph.D., MPH, answered a few questions about her work and the problem of health disparities for Black infants and mothers.

The ketogenic diet, or “keto” diet, can be a quick way to shed pounds. But it’s also a very strict diet. Learn about keto and how it’s being studied in individuals with Alzheimer’s disease.

Obesity is a complex national epidemic. The grant is intended to produce trainees who can think broadly about the condition from the laboratory to the clinic.

Controlling hypertension is important to brain health as well as to cardiovascular health, but the condition often is not well managed. Researchers at KU Medical Center have designed a home-based hypertension program they hope will help.

May Maloba, a doctoral student at the University of Kansas School of Nursing, brings her expertise in women’s health to Kenya, Cambodia and the United States.

See what shaped the University of Kansas Medical Center this year.

Clinical assistant professor Jennifer Cheng, M.D., is one of about 550 female board-certified neurosurgeons in the nation.

Studies in JAMA show that walking 10,000 steps can improve cardiovascular health and reduce risks of both dementia and cancer better than any pill or injection currently available.

Results of the study of the antiparasitic medication, once a much-discussed potential treatment for COVID-19, were published in the Journal of the American Medical Association.

Mazen Dimachkie, M.D., was one of 36 researchers from Europe and North America to recruit participants for the first large-scale, randomized control study investigating intravenous immune globulin as a treatment for dermatomyositis.

An observational study led by Halinder Mangat, M.D., demonstrated that rates of severe adverse events after COVID-19 immunization are very low compared with the risks from COVID-19.

TEAMSPORT will create a standardized approach to ordering genomic tests and adapt it for use in community cancer centers, where most cancer patients receive testing and treatment.

National call to action encourages use of low-dose CT to combat the leading cause of cancer in the United States

The Kansas Center for Metabolism and Obesity Research seeks to become a national hub for obesity-related research and the training of junior research faculty.

Radiation injury is a problematic side effect in cancer treatment, and radiation toxicity from radiological and nuclear devices has been a growing national concern since 9/11.

Thanks to a $3 million grant, the Kansas Leadership Education in Neurodevelopmental and related Disabilities program continues its five-decade mission of training, research and leadership development.

Founded in 1970 as the Institute of Medicine, the prestigious National Academy of Medicine has approximately 2,200 members worldwide.

‘Discover KU’s Health Programs’ invited students from Kansas City, Kansas, who would be the first generation in their families to go to college.

Their work will inform the design of drugs aiming to one day restore the function of that protein in order to prevent or treat the disease.

The KU Alzheimer’s Disease Research Center received a prestigious five-year, $1.5 million grant to expand and strengthen its program to boost brain health researchers.

Jeffrey Burns, co-director of the KU Alzheimer’s Disease Research Center, says early results of studies on lecanemab are promising.

KU Cancer Center oncology experts teamed up with statistical experts to warn those with leukemia and lymphoma of their increased risk of getting COVID-19

NCI recognition as a Comprehensive cancer center is the culmination of years of community effort and means that KU Cancer Center joins the top echelon of leading cancer experts.

Their algorithm could be implemented into hospitals’ electronic alert systems to help clinicians protect patients from kidney failure.

About 95% of participants achieved a measurable immune response after vaccination, according to study led by a KU School of Medicine professor and published in JAMA Oncology.

While engaged in many facets of population health research, Lee’s expertise lies in implementation science and health care delivery research in cancer prevention and control.

The five-year, NIH-funded COMET clinical trial is the largest of its kind to compare aerobic, resistance training or a combination of both while looking at cognition in older adults.

Equipment upgrade provides cutting-edge resources to researchers across the region

The University of Kansas Clinical Research Center (KU CRC), a dedicated clinical trials facility with support from a Johnson County sales tax, celebrates it's 10 year anniversary.

A symposium, held virtually Oct. 27-28, allowed scientists to learn about, and share, the latest research in PKD.

The work of Sarah Finocchario Kessler, Ph.D., MPH, supports the progressive efforts of Wyandotte County Health Department to address social needs of Covid-positive residents.

The University of Kansas Cancer Center is calling for public attention to this issue to prevent cancer deaths.

Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found after reviewing multiple studies.

Dennis Owens, MD, PhD, leading psychiatry department’s new clinical trial research